ATE135821T1 - Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren - Google Patents

Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren

Info

Publication number
ATE135821T1
ATE135821T1 AT90916889T AT90916889T ATE135821T1 AT E135821 T1 ATE135821 T1 AT E135821T1 AT 90916889 T AT90916889 T AT 90916889T AT 90916889 T AT90916889 T AT 90916889T AT E135821 T1 ATE135821 T1 AT E135821T1
Authority
AT
Austria
Prior art keywords
detecting
immunoglobulines
mixed
rheumatic factors
factors
Prior art date
Application number
AT90916889T
Other languages
English (en)
Inventor
Richard Weisbart
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE135821T1 publication Critical patent/ATE135821T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Buildings Adapted To Withstand Abnormal External Influences (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90916889T 1989-10-23 1990-10-03 Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren ATE135821T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42547489A 1989-10-23 1989-10-23
US51724690A 1990-05-01 1990-05-01

Publications (1)

Publication Number Publication Date
ATE135821T1 true ATE135821T1 (de) 1996-04-15

Family

ID=27026697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916889T ATE135821T1 (de) 1989-10-23 1990-10-03 Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren

Country Status (8)

Country Link
EP (1) EP0497886B1 (de)
JP (1) JP2905595B2 (de)
AT (1) ATE135821T1 (de)
CA (1) CA2070411A1 (de)
DE (1) DE69026106T2 (de)
DK (1) DK0497886T3 (de)
ES (1) ES2085917T3 (de)
WO (1) WO1991005873A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1484727A (fr) * 1966-04-19 1967-06-16 Réactif immunologique et son procédé d'obtention
DE2930706A1 (de) * 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
US4361647A (en) * 1980-05-22 1982-11-30 Palo Alto Medical Research Foundation Sandwich immunoassay and compositions for use therein
US4434227A (en) * 1982-02-08 1984-02-28 Abbott Laboratories Immunoassay for class specific immunoglobulin antibodies
EP0323785A1 (de) * 1987-12-28 1989-07-12 The Regents Of The University Of California Test für den IgvG-rheumatoiden Faktor

Also Published As

Publication number Publication date
DK0497886T3 (da) 1996-06-24
DE69026106T2 (de) 1996-10-24
CA2070411A1 (en) 1991-04-24
JPH05501919A (ja) 1993-04-08
DE69026106D1 (de) 1996-04-25
JP2905595B2 (ja) 1999-06-14
ES2085917T3 (es) 1996-06-16
WO1991005873A1 (en) 1991-05-02
EP0497886B1 (de) 1996-03-20
EP0497886A4 (en) 1992-10-14
EP0497886A1 (de) 1992-08-12

Similar Documents

Publication Publication Date Title
ATE40602T1 (de) Immunchemisches messverfahren.
DE3788397D1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
DE3484957D1 (de) Verfahren zum nachweis von immunkomplexen im serum.
ES515177A0 (es) Procedimiento para el tratamiento de inmunoglobulina de suero.
ATE15945T1 (de) Verfahren zum nachweis von haemoglobin in faezes.
DE3687884D1 (de) Monoklonale antikoerper und verfahren zum nachweis von pilzpathogenen.
ATE147167T1 (de) Oxidative denaturierung von eiweissanalyten
ATE76512T1 (de) Methode zum nachweis oder zur abschaetzung von biologischem material.
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
DE68907620D1 (de) Dichtungspruefverfahren von kunststoff-behaeltern.
ATE1256T1 (de) Diagnostisches mittel und verfahren zum nachweis von antimitochondrialen oder antinukleaeren antikoerpern.
ATE55059T1 (de) Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen.
ATE135821T1 (de) Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren
ATE137864T1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE3587542D1 (de) Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren.
FI881122A (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
DE3874741D1 (de) Immunassay-verfahren.
ATE60445T1 (de) Verfahren und testelement zum auffinden von zellaesionen.
GR3030212T3 (en) Platelet activating factor antagonists.
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
EP0248147A3 (de) Verfahren zur Bestimmung der Anwesenheit von Krebszellen
KR900018678A (ko) 엘라스타제-1의 면역 분석법
ES2070833T3 (es) Procedimiento para la determinacion cuantitativa de proteinas del suero en liquidos corporales y agente para realizar el procedimiento.
IT8706605A0 (it) Test in immunofluorescenza per la ricerca di anticorpi antileishmania donovani nel siero

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee